Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Vasomotor Symptoms”

30 trials

Showing 20 of 30 results

Large-scale testing (Phase 3)Study completedNCT05033886
What this trial is testing

Fezolinetant to Treat Hot Flashes in Women Going Through Menopause

Who this might be right for
Vasomotor Symptoms
Astellas Pharma Global Development, Inc. 453
Testing effectiveness (Phase 2)Study completedNCT03596762
What this trial is testing

BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms

Who this might be right for
MenopauseHot FlashesNight Waking
Bayer 199
Large-scale testing (Phase 3)Study completedNCT00535288
What this trial is testing

Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)

Who this might be right for
Postmenopausal SymptomsMenopauseVasomotor Symptoms
Merck Sharp & Dohme LLC 946
Large-scale testing (Phase 3)Study completedNCT04209543
What this trial is testing

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)

Who this might be right for
Vasomotor SymptomsMenopausal Symptoms
Estetra 1,570
Not applicableStudy completedNCT05300568
What this trial is testing

A Survey About Trade-offs When Choosing Menopause Treatments

Who this might be right for
Moderate to Severe Vasomotor Symptoms
Astellas Pharma Europe Ltd. 1,465
Large-scale testing (Phase 3)Study completedNCT00560833
What this trial is testing

Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012)

Who this might be right for
MenopauseVasomotor Symptoms
Merck Sharp & Dohme LLC 943
Large-scale testing (Phase 3)Study completedNCT00727129
What this trial is testing

Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms

Who this might be right for
Postmenopausal Symptoms
Upsher-Smith Laboratories 495
Testing effectiveness (Phase 2)Ended earlyNCT06161792
What this trial is testing

Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast Cancer

Who this might be right for
Hot FlashesBreast Cancer
Yung Shin Pharm. Ind. Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT00604825
What this trial is testing

Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

Who this might be right for
Menopausal and Female Climacteric States
GlaxoSmithKline 356
Testing effectiveness (Phase 2)Study completedNCT06726850
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of GS1-144 Tablets in the Treatment of Moderate to Severe Vasomotor Symptoms in Chinese Postmenopausal Women.

Who this might be right for
Vasomotor Syndrome
Changchun GeneScience Pharmaceutical Co., Ltd. 129
Large-scale testing (Phase 3)Study completedNCT00446199
What this trial is testing

Low-dose Hormone Therapy for Relief of Vasomotor Symptoms

Who this might be right for
Vasomotor SymptomsHot Flashes
Bayer 735
Testing effectiveness (Phase 2)Study completedNCT03541200
What this trial is testing

Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms

Who this might be right for
Vasomotor Symptoms (VMS)
Tanabe Pharma America, Inc. 190
Post-approval studies (Phase 4)Study completedNCT02195609
What this trial is testing

Evaluate the Effect of Omega-3 vs Soy Isoflavones in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Who this might be right for
MenopauseHot Flashes
Instituto Palacios 75
Large-scale testing (Phase 3)Study completedNCT04003142
What this trial is testing

Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2

Who this might be right for
Hot Flashes
Astellas Pharma Global Development, Inc. 501
Testing effectiveness (Phase 2)Study completedNCT05325775
What this trial is testing

Dose-ranging, PK, Safety, Efficacy Study of Osanetant in Patients With Moderate/Severe VMS Associated With Menopause

Who this might be right for
Post-menopausal Vasomotor Symptoms
Acer Therapeutics Inc. 49
Large-scale testing (Phase 3)Study completedNCT04003155
What this trial is testing

Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause

Who this might be right for
Hot Flashes
Astellas Pharma Global Development, Inc. 527
Testing effectiveness (Phase 2)Study completedNCT06812754
What this trial is testing

Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause

Who this might be right for
Hot Flashes
Astellas Pharma Global Development, Inc. 150
Large-scale testing (Phase 3)Study completedNCT04234204
What this trial is testing

Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through Menopause

Who this might be right for
Hot Flashes
Astellas Pharma China, Inc. 302
Testing effectiveness (Phase 2)Ended earlyNCT04278872
What this trial is testing

Phase 2 Study of SJX-653 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Who this might be right for
Hot Flashes
Sojournix, Inc. 13
Large-scale testing (Phase 3)Study completedNCT04090957
What this trial is testing

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)

Who this might be right for
Vasomotor SymptomsMenopausal Symptoms
Estetra 1,015
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation